The problem is on a scale of priorities BIS to monitor lymphoedema will be well down the list. Hospitals are too busy savings lives and keeping people alive. Funding will go to critical needs first. The market is not there for lymphoedema alone to be a company maker… either they face reality and scale down the business to suit demand or shareholders face never ending dilution into oblivion.
Add to My Watchlist
What is My Watchlist?
